Principal Display Package (Eribulin Mesylate Injection 1 mg/2 mL Carton)
This text contains information about Eribulin Mesylate Injection, including dosage, composition, storage instructions, and cautions related to its cytotoxic nature. It provides details such as the concentration of the drug per volume, temperature storage requirements, and the need for pH adjustment. The product is intended for intravenous use, and each single-dose vial should be discarded if unused. Additional details may be found in the prescribing information. The drug is manufactured by a company located in China.*